Neil Kaplowitz

41.1k total citations · 8 hit papers
314 papers, 30.6k citations indexed

About

Neil Kaplowitz is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Neil Kaplowitz has authored 314 papers receiving a total of 30.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pharmacology, 96 papers in Molecular Biology and 92 papers in Epidemiology. Recurrent topics in Neil Kaplowitz's work include Liver Disease Diagnosis and Treatment (86 papers), Drug-Induced Hepatotoxicity and Protection (81 papers) and Sulfur Compounds in Biology (75 papers). Neil Kaplowitz is often cited by papers focused on Liver Disease Diagnosis and Treatment (86 papers), Drug-Induced Hepatotoxicity and Protection (81 papers) and Sulfur Compounds in Biology (75 papers). Neil Kaplowitz collaborates with scholars based in United States, Spain and China. Neil Kaplowitz's co-authors include José C. Fernández‐Checa, Cheng Ji, Murad Ookhtens, Carmen García‐Ruiz, Derick Han, Zhang‐Xu Liu, Thomas Kiernan, Laurie D. DeLeve, Jerome S. Wollman and William C. Black and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Neil Kaplowitz

311 papers receiving 29.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

1981 3.1k citations Robert G. Knodell, Kamal G. Ishak et al. Hepatology profile →
Idiosyncratic drug hepatotoxicity

2005 753 citations Neil Kaplowitz profile →
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

2011 713 citations Guruprasad P. Aithal, Raúl J. Andrade et al. Clinical Pharmacology & Therapeutics profile →
EASL Clinical Practice Guidelines: Drug-induced liver injury

2019 710 citations Raúl J. Andrade, Guruprasad P. Aithal et al. Journal of Hepatology profile →
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

2014 573 citations Neil Kaplowitz et al. profile →
The Regulation of Hepatic Glutathione

1985 541 citations Neil Kaplowitz, Murad Ookhtens et al. profile →
Drug-induced liver injury

2019 537 citations Raúl J. Andrade, Einar S. Björnsson et al. profile →
Endoplasmic reticulum stress in liver diseases

2022 224 citations Neil Kaplowitz et al. Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Neil Kaplowitz	9.7k	9.2k	8.4k	7.9k	4.4k	314	30.6k
Hartmut Jaeschke	9.1k 0.9×	15.2k 1.6×	8.2k 1.0×	12.2k 1.5×	5.6k 1.3×	399	34.7k
Magnus Ingelman‐Sundberg	3.6k 0.4×	18.2k 2.0×	10.8k 1.3×	2.2k 0.3×	7.8k 1.8×	527	35.5k
Charles S. Lieber	12.2k 1.3×	5.7k 0.6×	7.3k 0.9×	3.5k 0.4×	1.5k 0.3×	423	31.5k
Ronald G. Thurman	5.6k 0.6×	2.8k 0.3×	5.7k 0.7×	4.6k 0.6×	1.2k 0.3×	388	19.6k
Craig J. McClain	11.2k 1.1×	2.3k 0.3×	8.4k 1.0×	3.3k 0.4×	1.4k 0.3×	576	28.9k
Geoffrey C. Farrell	19.9k 2.0×	2.1k 0.2×	4.7k 0.6×	10.0k 1.3×	1.6k 0.4×	213	26.1k
Dominique Pessayre	5.4k 0.6×	5.0k 0.5×	4.2k 0.5×	2.6k 0.3×	2.1k 0.5×	248	14.6k
Ramón Bataller	16.2k 1.7×	1.9k 0.2×	5.2k 0.6×	12.0k 1.5×	1.4k 0.3×	307	25.4k
Arthur I. Cederbaum	5.1k 0.5×	4.0k 0.4×	6.7k 0.8×	1.3k 0.2×	1.3k 0.3×	351	19.1k
James L. Boyer	6.2k 0.6×	2.5k 0.3×	5.1k 0.6×	5.8k 0.7×	10.3k 2.3×	366	21.2k

Countries citing papers authored by Neil Kaplowitz

Since Specialization

Citations

This map shows the geographic impact of Neil Kaplowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Kaplowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Kaplowitz more than expected).

Fields of papers citing papers by Neil Kaplowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Kaplowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Kaplowitz. The network helps show where Neil Kaplowitz may publish in the future.

Co-authorship network of co-authors of Neil Kaplowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Kaplowitz. A scholar is included among the top collaborators of Neil Kaplowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Kaplowitz. Neil Kaplowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Win, Sanda, Tin Aung Than, Neil Kaplowitz, et al.. (2024). The central role of mitochondrial metabolism in hepatic steatosis. SHILAP Revista de lepidopterología. 42–68. 10 indexed citations

García‐Cortés, Miren, Aida Ortega‐Alonso, Inmaculada Medina‐Cáliz, et al.. (2023). Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver International. 43(8). 1749–1760. 13 indexed citations

Win, Sanda, Tin Aung Than, & Neil Kaplowitz. (2022). c- Jun -N Terminal Kinase-Mediated Degradation of γ-Glutamylcysteine Ligase Catalytic Subunit Inhibits GSH Recovery After Acetaminophen Treatment: Role in Sustaining JNK Activation and Liver Injury. Antioxidants and Redox Signaling. 38(16-18). 1071–1081. 10 indexed citations

Álvarez‐Álvarez, Ismael, Inmaculada Medina‐Cáliz, Judith Sanabria‐Cabrera, et al.. (2020). Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old. Clinical Pharmacology & Therapeutics. 109(4). 1147–1158. 17 indexed citations

Andrade, Raúl J., Guruprasad P. Aithal, Einar S. Björnsson, et al.. (2019). EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology. 70(6). 1222–1261. 710 indexed citations breakdown →

Suda, Jo, Lily Dara, Mariam Aghajan, et al.. (2016). Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. The Journal of Immunology. 197(8). 3120–3129. 45 indexed citations

Huo, Yazhen, Sanda Win, Tin Aung Than, et al.. (2016). Antcin H Protects Against Acute Liver Injury Through Disruption of the Interaction of c-Jun-N-Terminal Kinase with Mitochondria. Antioxidants and Redox Signaling. 26(5). 207–220. 47 indexed citations

Xu, Chun‐Fang, Toby Johnson, Xiaojing Wang, et al.. (2015). HLA-B *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer. Clinical Cancer Research. 22(6). 1371–1377. 70 indexed citations

Kaplowitz, Neil & Laurie D. DeLeve. (2013). Drug-Induced Liver Disease Ed. 3. Elsevier eBooks. 4 indexed citations

10.

Lou, Huan, Murad Ookhtens, Andrew Stolz, & Neil Kaplowitz. (2003). Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(6). G1335–G1344. 21 indexed citations

11.

Wolkoff, Allan W., et al.. (2002). The Thiol Sensitivity of Glutathione Transport in Sidedness-Sorted Basolateral Liver Plasma Membrane and in Oatp1-Expressing HeLa Cell Membrane. Molecular Pharmacology. 61(2). 425–435. 2 indexed citations

12.

Kaplowitz, Neil, et al.. (2000). Radiation inactivation studies of hepatic sinusoidal reduced glutathione transport system. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1464(2). 207–218. 6 indexed citations

13.

García‐Ruiz, Carmen, Albert Morales, Anna Colell, et al.. (1995). Feeding S -adenosyl-l-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology. 21(1). 207–214. 183 indexed citations

14.

García‐Ruiz, Carmen, Albert Morales, Antonio M. Ballesta, et al.. (1994). Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes.. Journal of Clinical Investigation. 94(1). 193–201. 193 indexed citations

15.

Kaplowitz, Neil. (1992). Liver and biliary diseases. Williams & Wilkins eBooks. 66 indexed citations

16.

Kaplowitz, Neil, et al.. (1983). Factors influencing the efflux of hepatic glutathione into bile in rats.. Journal of Pharmacology and Experimental Therapeutics. 224(1). 141–147. 74 indexed citations

17.

Knodell, Robert G., Kamal G. Ishak, William C. Black, et al.. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†. Hepatology. 1(5). 431–435. 3063 indexed citations breakdown →

18.

Kaplowitz, Neil, et al.. (1980). Effect of salicylates and phenobarbital on hepatic glutathione in the rat.. Journal of Pharmacology and Experimental Therapeutics. 212(2). 240–245. 44 indexed citations

19.

Wallin, John D., et al.. (1977). Metabolic clearance of furosemide in the rat.. Journal of Pharmacology and Experimental Therapeutics. 200(1). 52–57. 13 indexed citations

20.

Kaplowitz, Neil, I W Percy-Robb, & Norman B. Javitt. (1973). ROLE OF HEPATIC ANION-BINDING PROTEIN IN BROMSULPHTHALEIN CONJUGATION. The Journal of Experimental Medicine. 138(2). 483–487. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact